A Cytosolic Sperm Protein Factor Mobilizes Ca2+ from Intracellular Stores by Activating Multiple Ca2+ Release Mechanisms Independently of Low Molecular Weight Messengers*
- From the ‡University Department of Pharmacology, Oxford University, Mansfield Road, Oxford OX1 3QT, the‖Medical Research Council National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, and the¶Department of Anatomy and Developmental Biology, University College London, Gower Street, London WC1E 6BT, United Kingdom
Abstract
Ca2+ oscillations can be induced in mammalian eggs and somatic cells by microinjection of a cytosolic sperm protein factor. The nature of the sperm factor-induced Ca2+ signaling was investigated by adding sperm protein extracts to homogenates of sea urchin eggs, which contain multiple classes of Ca2+ release mechanisms. We show that the sperm factor mobilizes Ca2+ from non-mitochondrial Ca2+ stores in egg homogenates after a distinct latency. This latency is abolished by preincubation of sperm extracts with egg cytosol. The preincubation step is highly temperature-dependent and generates a high molecular weight, protein-based Ca2+-releasing agent that can also mobilize Ca2+ from purified egg microsomes. This Ca2+ release appears to be mediated via both inositol 1,4,5-trisphosphate and ryanodine receptors, since homologous desensitization of these two release mechanisms by their respective agonists inhibits further release by the sperm factor. However, sperm factor-induced Ca2+ release by these channels is independent of inositol 1,4,5-trisphosphate or cADPR since antagonists of either of these two messengers did not block the Ca2+release effected by the sperm factor. The sperm protein factor may cause Ca2+ release via an enzymatic step that generates a protein-based Ca2+-releasing agent.
Footnotes
-
↵* This work was supported by grants (to K. S., K. J., and A. G.) from the Medical Research Council and the Wellcome Trust.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
↵§ To whom correspondence should be addressed. Tel.: 44-1865-271633; Fax: 44-1865-271853; E-mail: antony.galione{at}pharm.ox.ac.uk.
-
↵** To whom correspondence should be addressed.
-
↵1 The abbreviations used are: InsP3, inositol 1,4,5-trisphosphate; RyR, ryanodine receptor; cADPR, cyclic adenosine diphosphate ribose.
-
- Received August 29, 1997.











